FDA Inspection 1065580 — Aap Biomaterials, GmbH

Aap Biomaterials, GmbH — FEI 3005568854

The FDA completed an inspection of Aap Biomaterials, GmbH on Sep 6, 2018 in Dieburg. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 4 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Sep 6, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Dieburg (Germany)

Citations

IDCFRDescription
1471221 CFR 820.184DHR - not or inadequately maintained
1471621 CFR 820.30(f)Design verification - output does not meet input requirement
343321 CFR 820.75(c)Process changes - review, evaluation and revalidation
63121 CFR 803.17(a)(1)Lack of System for Event Evaluations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.